Invus Public Equities, L.P. 13D and 13G filings for Neumora Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-19 4:37 pm Purchase | 2026-02-13 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | Invus Public Equities, L.P. | 8,997,822 5.400% | 8,997,822 (New Position) | Filing |